Human Genome Epidemiology Literature Finder
Records 1 - 28 (of 28 Records) |
Query Trace: Schizophrenia and CNR1[original query] |
---|
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Molecular psychiatry 2002 7 (5): 515-8. Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M, Fujiwara Y, Sakai A, Kuroda |
(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. The pharmacogenomics journal 0 6 (2): 126-30. Ballon N, Leroy S, Roy C, Bourdel M C, Charles-Nicolas A, Krebs M O, Poirier M |
(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population. European archives of psychiatry and clinical neuroscience 2006 Oct 256 (7): 437-41. Martínez-Gras Isabel, Hoenicka Janet, Ponce Guillermo, Rodríguez-Jiménez Roberto, Jiménez-Arriero Miguel Angel, Pérez-Hernandez Elena, Ampuero Israel, Ramos-Atance Jose Antonio, Palomo Tomas, Rubio Gabri |
No association of CNR1 gene variations with susceptibility to schizophrenia. Neuroscience letters 2007 Oct 426 (1): 29-33. Seifert Jürgen, Ossege Sebastian, Emrich Hinderk M, Schneider Udo, Stuhrmann Manfr |
Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. The British journal of psychiatry : the journal of mental science 2007 Nov 191 402-7. Zammit Stanley, Spurlock Gillian, Williams Hywel, Norton Nadine, Williams Nigel, O'Donovan Michael C, Owen Michael |
Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008 Apr 147 (3): 279-84. Chavarría-Siles Iván, Contreras-Rojas Javier, Hare Elizabeth, Walss-Bass Consuelo, Quezada Paulina, Dassori Albana, Contreras Salvador, Medina Rolando, Ramírez Mercedes, Salazar Rodolfo, Raventos Henriette, Escamilla Michael |
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010 May 35 (6): 1315-24. Tiwari Arun K, Zai Clement C, Likhodi Olga, Lisker Annika, Singh Deepika, Souza Renan P, Batra Poonam, Zaidi Syed H E, Chen Sheng, Liu Fang, Puls Imke, Meltzer Herbert Y, Lieberman Jeffrey A, Kennedy James L, Müller Daniel |
Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain. Human psychopharmacology 2011 Jun . Park YM, Choi JE, Kang SG, Koo SH, Kim L, Geum D, Lee HJ |
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential. Neuroscience letters 2011 May 496 (1): 60-4. Stadelmann Andreas M, Juckel Georg, Arning Larissa, Gallinat Jürgen, Epplen Jörg T, Roser Patr |
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophrenia research 2011 May 128 (1-3): 66-75. Ho Beng-Choon, Wassink Thomas H, Ziebell Steven, Andreasen Nancy |
Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia. The pharmacogenomics journal 2012 Jun 12 (3): 260-6. Tiwari A K, Zai C C, Likhodi O, Voineskos A N, Meltzer H Y, Lieberman J A, Potkin S G, Remington G, Müller D J, Kennedy J |
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-a gene (PPARA) and schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2013 Jul 23 (7): 749-59. Costa Marta, Squassina Alessio, Congiu Donatella, Chillotti Caterina, Niola Paola, Galderisi Silvana, Pistis Marco, Del Zompo Mar |
MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychological medicine 2013 Mar 43 (3): 619-31. Onwuameze O E, Nam K W, Epping E A, Wassink T H, Ziebell S, Andreasen N C, Ho B |
CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia. Journal of clinical psychopharmacology 2013 Apr 33 (2): 186-92. Yu Weiping, De Hert Marc, Moons Tim, Claes Stephan J, Correll Christoph U, van Winkel Ru |
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population. Psychiatric genetics 2014 Oct 24 (5): 225-9. Bae Joon Seol, Kim Jason Yongha, Park Byung-Lae, Kim Jeong-Hyun, Kim Bomi, Park Chul Soo, Kim Bong-Jo, Lee Cheol-Soon, Lee Migyung, Choi Woo Hyuk, Shin Tae-Min, Hwang Jaeuk, Shin Hyoung Doo, Woo Sung- |
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms. Psychiatry research 2015 Aug 233 (2): 112-9. Suárez-Pinilla Paula, Roiz-Santiañez Roberto, Ortiz-García de la Foz Víctor, Guest Paul C, Ayesa-Arriola Rosa, Córdova-Palomera Aldo, Tordesillas-Gutierrez Diana, Crespo-Facorro Benedic |
The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway. Neuroscience 2015 Oct . Xie J, Gizatullin R, Vukojevic V, Leopardi |
The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 2017 1 39 (2): 160-171. Gouvêa Eduardo S, Santos Airton F, Ota Vanessa K, Mrad Vinicius, Gadelha Ary, Bressan Rodrigo A, Cordeiro Quirino, Belangero Sintia |
Detection of Significant Association Between Variants in Cannabinoid Receptor 1 Gene (CNR1) and Personality in African-American Population. Frontiers in genetics 2018 9 199. Yao Yinghao, Xu Yi, Zhao Junsheng, Ma Yunlong, Su Kunkai, Yuan Wenji, Ma Jennie Z, Payne Thomas J, Li Ming |
Accessing Gene Expression in Treatment-Resistant Schizophrenia. Molecular neurobiology 2018 1 55 (8): 7000-7008. Moretti Patricia N, Ota Vanessa K, Gouvea Eduardo S, Pedrini Mariana, Santoro Marcos L, Talarico Fernanda, Spindola Leticia M, Carvalho Carolina Muniz, Noto Cristiano, Xavier Gabriela, Brietzke Elisa, Gadelha Ary, Bressan Rodrigo, Mari Jair, Belangero Sint |
Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia. Translational psychiatry 2020 5 10 (1): 158. Tao Ran, Li Chao, Jaffe Andrew E, Shin Joo Heon, Deep-Soboslay Amy, Yamin Rae'e, Weinberger Daniel R, Hyde Thomas M, Kleinman Joel |
Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 2021 Jun . Ferretjans Rodrigo, de Souza Renan P, Panizzutti Bruna, Ferrari Pâmela, Mantovani Lucas, de Campos-Carli Salvina M, Santos Rafael R, Guimarães Fernanda C, Teixeira Antonio L, Gama Clarissa S, Salgado João |
Cannabinoid receptor type 2 gene is associated with comorbidity of schizophrenia and cannabis dependence and fatty acid amide hydrolase gene is associated with cannabis dependence in the Spanish population. Adicciones 2021 Jun 0 (0): 1587. Arias Horcajadas Francisco, Dávila Píriz José Ramón, Parra González Alba, Sánchez Romero Sergio, Sánchez-Morla Eva, Ampuero Sánchez Israel, Ramos Atance José Anton |
Fibromyalgia: A Review of Related Polymorphisms and Clinical Relevance. Anais da Academia Brasileira de Ciencias 2021 11 93 (suppl 4): e20210618. Janssen Luísa P, Medeiros Liciane F, Souza Andressa DE, Silva Juliana |
Polymorphisms in Schizophrenia-Related Genes Are Potential Predictors of Antipsychotic Treatment Resistance and Refractoriness. The international journal of neuropsychopharmacology 2022 4 25 (9): 701-708. Zazueta Alejandra, Castillo Tito, Cavieres Álvaro, González René, Abarca Maximiliano, Nieto Rodrigo R, Deneken Javier, Araneda Cristian, Moya Pablo R, Bustamante M Leon |
Associations between polymorphisms in the cannabinoid receptor 1 gene, cognitive impairments and tardive dyskinesia in a Chinese population with schizophrenia. Brain research 2023 9 1821 148579. Chenghao Lu, Shen Li, Yanzhe Li, Xiaofei Zhang, Jinghui Chi, Qiaona Jiang, Yanyan Ma, Xiaomei Shi, Lili Wang, Jie |
GENETIC VARIANTS IN ANTIPSYCHOTIC METABOLISM: POLYMORPHISM PROFILES IN KAZAKH COHORT WITH PARANOID SCHIZOPHRENIA. Georgian medical news 2024 12 (355): 99-103. K Kovaleva, Z Kachiyeva, A Abetova, N Raspopo |
Genetic and Neurodevelopmental Markers in Schizophrenia-Spectrum Disorders: Analysis of the Combined Role of the CNR1 Gene and Dermatoglyphics. Biomedicines 2024 10 12 (10): . Maria Guardiola-Ripoll, Alejandro Sotero-Moreno, Boris Chaumette, Oussama Kebir, Noemí Hostalet, Carmen Almodóvar-Payá, Mónica Moreira, Maria Giralt-López, Marie-Odile Krebs, Mar Fatjó-Vil |
- Page last reviewed:Feb 1, 2024
- Content source: